儿童多系统炎症综合征（MIS-C）和轻度及重度 2019 冠状病毒病（COVID-19）患儿的严重急性呼吸综合征冠状病毒 2（SARS-CoV-2）抗体反应。
Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) Antibody Responses in Children With Multisystem Inflammatory Syndrome in Children (MIS-C) and Mild and Severe Coronavirus Disease 2019 (COVID-19).
机构信息
Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Immune Dysregulation Frontier Program, Department of Pediatrics, Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
出版信息
J Pediatric Infect Dis Soc. 2021 May 28;10(5):669-673. doi: 10.1093/jpids/piaa161.
Abstract
Severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) antibody responses in children remain poorly characterized. Here, we show that pediatric patients with multisystem inflammatory syndrome in children (MIS-C) possess higher SARS-CoV-2 spike immunoglobulin G (IgG) titers compared with those with severe coronavirus disease 2019, likely reflecting a longer time since the onset of infection in MIS-C patients.
摘要
儿童严重急性呼吸综合征冠状病毒 2（SARS-CoV-2）抗体反应仍知之甚少。在这里，我们表明患有儿童多系统炎症综合征（MIS-C）的儿科患者的 SARS-CoV-2 刺突免疫球蛋白 G（IgG）滴度高于患有严重 2019 年冠状病毒病（COVID-19）的患者，这可能反映了 MIS-C 患者感染后时间更长。
相似文献
1
Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) Antibody Responses in Children With Multisystem Inflammatory Syndrome in Children (MIS-C) and Mild and Severe Coronavirus Disease 2019 (COVID-19).
J Pediatric Infect Dis Soc. 2021 May 28;10(5):669-673. doi: 10.1093/jpids/piaa161.
2
Quantitative SARS-CoV-2 Serology in Children With Multisystem Inflammatory Syndrome (MIS-C).
Pediatrics. 2020 Dec;146(6). doi: 10.1542/peds.2020-018242. Epub 2020 Sep 2.
3
SARS-CoV-2 immune repertoire in MIS-C and pediatric COVID-19.
Nat Immunol. 2021 Nov;22(11):1452-1464. doi: 10.1038/s41590-021-01051-8. Epub 2021 Oct 5.
4
Distinct antibody responses to SARS-CoV-2 in children and adults across the COVID-19 clinical spectrum.
Nat Immunol. 2021 Jan;22(1):25-31. doi: 10.1038/s41590-020-00826-9. Epub 2020 Nov 5.
5
SARS-CoV-2-Specific T Cell Responses Are Stronger in Children With Multisystem Inflammatory Syndrome Compared to Children With Uncomplicated SARS-CoV-2 Infection.
Front Immunol. 2022 Jan 18;12:793197. doi: 10.3389/fimmu.2021.793197. eCollection 2021.
6
A poor and delayed anti-SARS-CoV2 IgG response is associated to severe COVID-19 in children.
EBioMedicine. 2021 Oct;72:103615. doi: 10.1016/j.ebiom.2021.103615. Epub 2021 Oct 11.
7
Original antigenic sin responses to Betacoronavirus spike proteins are observed in a mouse model, but are not apparent in children following SARS-CoV-2 infection.
PLoS One. 2021 Aug 27;16(8):e0256482. doi: 10.1371/journal.pone.0256482. eCollection 2021.
8
Quantitative Antibody Levels Against SARS-CoV-2 Spike Protein in COVID-19 and Multisystem Inflammatory Syndrome in Children.
Viral Immunol. 2022 Dec;35(10):681-689. doi: 10.1089/vim.2022.0089.
9
Antibody response in children with multisystem inflammatory syndrome related to COVID-19 (MIS-C) compared to children with uncomplicated COVID-19.
Front Immunol. 2023 Mar 15;14:1107156. doi: 10.3389/fimmu.2023.1107156. eCollection 2023.
10
Assessment of S1-, S2-, and NCP-Specific IgM, IgA, and IgG Antibody Kinetics in Acute SARS-CoV-2 Infection by a Microarray and Twelve Other Immunoassays.
J Clin Microbiol. 2021 Apr 20;59(5). doi: 10.1128/JCM.02890-20.
引用本文的文献
1
The complex landscape of immune dysregulation in multisystem inflammatory syndrome in children with COVID-19.
Life Med. 2024 Sep 13;3(4):lnae034. doi: 10.1093/lifemedi/lnae034. eCollection 2024 Aug.
2
Immunologic Predictors of Vaccine Responsiveness in Patients With Lymphoma and Chronic Lymphocytic Leukemia.
J Infect Dis. 2024 Jul 25;230(1):15-27. doi: 10.1093/infdis/jiae106.
3
SARS-CoV-2 Seroepidemiology and Antibody Levels in Children during BA.5 Predominance Period.
Diagnostics (Basel). 2024 May 17;14(10):1039. doi: 10.3390/diagnostics14101039.
4
Cellugyrin (synaptogyrin-2) dependent pathways are used by bacterial cytolethal distending toxin and SARS-CoV-2 virus to gain cell entry.
Front Cell Infect Microbiol. 2024 Apr 18;14:1334224. doi: 10.3389/fcimb.2024.1334224. eCollection 2024.
5
IgG3 subclass antibodies recognize antigenically drifted influenza viruses and SARS-CoV-2 variants through efficient bivalent binding.
Proc Natl Acad Sci U S A. 2023 Aug 29;120(35):e2216521120. doi: 10.1073/pnas.2216521120. Epub 2023 Aug 21.
6
Defining the pediatric response to SARS-CoV-2 variants.
Front Immunol. 2023 May 25;14:1200456. doi: 10.3389/fimmu.2023.1200456. eCollection 2023.
7
SARS-CoV-2 Antibody Responses in Pediatric Patients: A Bibliometric Analysis.
Biomedicines. 2023 May 16;11(5):1455. doi: 10.3390/biomedicines11051455.
8
COVID-19 mRNA BNT162b2 vaccine immunogenicity among children with a history of paediatric multisystem inflammatory syndrome temporally associated with COVID-19 (PIMS-TS).
Vaccine. 2023 May 16;41(21):3317-3327. doi: 10.1016/j.vaccine.2023.04.035. Epub 2023 Apr 14.
9
Antibody response in children with multisystem inflammatory syndrome related to COVID-19 (MIS-C) compared to children with uncomplicated COVID-19.
Front Immunol. 2023 Mar 15;14:1107156. doi: 10.3389/fimmu.2023.1107156. eCollection 2023.
10
Severe COVID-19 multisystem inflammatory syndrome: comparing two critical outcomes of SARS-CoV-2 infection.
Eur Respir Rev. 2023 Mar 8;32(167). doi: 10.1183/16000617.0197-2022. Print 2023 Mar 31.
Zotero 插件